[1] 中华医学会风湿病学分会,国家皮肤与免疫疾病临床医学研究中心,中国系统性红斑狼疮研究协作组.2020中国系统性红斑狼疮诊疗指南[J].中华内科杂志,2020,59(3):172-185.
[2] 秦岭, 邱志锋, 谢静, 等.系统性红斑狼疮合并机会性感染的疾病谱及其外周血淋巴细胞亚群特点分析[J].中华内科杂志,2018,57(1):32-36.
[3] Pimentel-Quiroz VR, Ugarte-Gil MF, Harvey GB, et al. Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort[J].Lupus,2019,28(9): 1101-1110.
[4] Zhan ZP, Lao MX, Fan S, et al. Hospital-acquired infection in patients with systemic lupus erythematosus: a case-control study in a southern Chinese population[J].Clin Rheumatol,2018,37(3):709-717.
[5] Marcello F, Emanuele P, David U, et al. Erysipelothrix rhusiopathiae septicaemia in systemic lupus erythematosus[J].Infez Med,2018,26(4):356-358.
[6] Qiu CC,Caricchio R,Gallucci S.Triggers of autoimmunity: the role of bacterial infections in the extracellular exposure of lupus nuclear autoantigens[J].Front Immunol,2019,10:2608.
[7] Chen MJ, Tseng HM, Huang YL, et al. Long-term outcome and short-term survival of patients with systemic lupus erythematosus after bacteraemia episodes: 6-yr follow-up[J].Rheumatology (Oxford),2008,47(9):1352-1356.
[8] Gupta N, Nguyen CQ, Modica RF, et al. BK viruria and viremia in children with systemic lupus erythematosus[J].Pediatr Rheumatol Online J,2017,15(1):21.
[9] 李宝青, 张佳丽, 郭刚强, 等. 系统性红斑狼疮患者人巨细胞病毒抗体检测的临床意义[J].中国卫生检验杂志, 2019,29(1): 48-51.
[10] 杨大伟, 臧欢欢, 黄玉萍, 等. EB病毒及人巨细胞病毒近期感染参与系统性红斑狼疮疾病活动临床分析[J].齐齐哈尔医学院学报, 2018,39(18):2109-2113.
[11] Pisetsky DS.Role of Epstein-Barr virus infection in SLE:gene-environment interactions at the molecular level[J].Ann Rheum Dis,2018,77(9):1249-1250.
[12] 于水莲, 陶怡, 黄文辉, 等. Toll样受体7在系统性红斑狼疮合并高危人乳头瘤病毒感染中的作用[J].广东医学, 2016,37(2):236-241.
[13] Wang LR, Barber CE, Johnson AS, et al. Invasive fungal disease in systemic lupus erythematosus: a systematic review of disease characteristics, risk factors, and prognosis[J].Semin Arthritis Rheum,2014,44(3):325-330.
[14] 郭芸, 谈鑫, 邸宇姿, 等.系统性红斑狼疮并发侵袭性真菌病27例临床分析[J].中国皮肤性病学杂志, 2017,31(9):980-983.
[15] Sazliyana SS, Narisa SS, Zeena MF, et al. Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis[J].Clin Rheumatol,2018,37(3):837-847.
[16] Li Y, Ghannoum M, Deng C, et al. Pneumocystis pneumonia in patients with inflammatory or autoimmune diseases: usefulness of lymphocyte subtyping[J].Int J Infect Dis,2017,57:108-115.
[17] Wang ZG,Liu XM,Wang Q,et al. A retrospective study of patients with systemic lupus erythematosus combined with Pneumocystis jiroveci pneumonia treated with caspofungin and trimethoprim/sulfamethoxazole[J].Medicine,2019,98(23):e15997.
[18] 马晓莉, 马凤莲, 马增瑞, 等.淋巴细胞亚群、降钙素原及超敏C反应蛋白检测对系统性红斑狼疮合并感染的诊断价值分析[J].宁夏医学杂志, 2019,41(5):409-412.
[19] Wang KC, Liu PH, Yu KH, et al. Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode[J].Immunol Lett,2017,185:84-89.
[20] 何映琴, 菅宏蕴, 谢志斌. 血清降钙素原鉴别系统性红斑狼疮患者发热原因的价值分析[J].现代诊断与治疗,2016,27(3):486-488.
[21] Ilaria S, Laurent A, Alexis M, et al. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review[J].Clin Rheumatol,2014,33(9):1209-1215.
[22] Mageau A, Sacré K, Perozziello A, et al. Septic shock among patients with systemic lupus erythematosus: Short and long-term outcome. Analysis of a French nationwide database[J].J Infect,2019,78(6):432-438.
[23] Yang SC, Lai YY, Huang MC.Corticosteroid dose and the risk of opportunistic infection in a national systemic lupus erythematosus cohort[J].Lupus,2018,27(11):1819-1827. |
2021, Vol. 38 
